English court backs NHS in fight with Bayer, Novartis over off-label Avastin use | FiercePharma
Off‐label drug use – price analysis for Avastin® in ophthalmology | Emerald Insight
Avastin, Lucentis & Zaltrap, Eylea - ppt download
EFPIA Files Complaint Against French Law Promoting Off-Label Avastin Use – Policy & Medicine
MHRA clarifies position on off-label Avastin - PharmaTimes
Avastin Injections Are Said to Cause Blindness - The New York Times
PharmaBoardroom - EU Ruling likely to set an increase in off-label use of medicinal products.
EU rules Avastin can be reimbursed for off-label use
Avastin. Patient safety or profit?
NHS wins legal fight with pharma over off-label Avastin - PMLiVE
Roche Fights Off Challenge To Off-Label Use Of Avastin For Treatment Of Wet AMD - Enable Law
Quality issues not behind sight loss in off-label Avastin use in India | FiercePharma
NHS wins case to prescribe cheaper ophthalmology drug
Avastin Lawsuits - Off-Label Use, Eye Infection, Blindness Risk
Italy free to reimburse off-label Avastin, rules EU court -
avastin - Diabetic Retinopathy
Avastin authorized for UK advanced cervical cancer patients
Significant Number Of Drugs Will Launch For The Treatment Of Age-Related Macular Degeneration By 2026 Says GlobalData
Off-Label Use of Drugs and Access to Medicines for All: A Thailand Example | Council on Foreign Relations
Avastin fights early breast cancer in 2 studies: Will it be re-approved? - CBS News
What Does 'Off Label' Mean in 2014?
PDF) Some ethical considerations for the “off-label” use of drugs as Avastin
Doctors appeal to prescribe Avastin off-label | Pharmafile
French Regulator and Roche Trade Blows Over Off-Label Avastin Use | RAPS
Lucentis biosimilar could offer safer option than Avastin, says Pfenex
